We organize and sponsor international workshops to facilitate one of the key missions of the BioMed21 collaboration – to bring relevant players together in order to identify opportunities, acknowledge existing barriers, and make recommendations necessary for implementation of a human biology platform for biomedical research. Here you can learn about our events: the speakers, their presentations, and formal accounts of the workshops, including our published workshop reports.
UPCOMING
There are currently no upcoming events.
PAST
2019 – May
BioMed21: Science without Animal Use
National Assembly, Seoul, South Korea
2019 – April
Cosmetic Risk Assessment and Regulatory Application of Non-animal Testing Technology
Shanghai, China
- Agenda / Workshop handbook
- Plenary lecture (Catherine Willett)
- Workshop report (in Mandarin Chinese)
2019 – March
Humane Society International Symposium on Global Harmonization of Vaccine Testing Requirements
Rome, Italy
- Agenda
- Symposium program
- Scientific rationale
- Presentations
- Flash report
- Flash report (Chisese translation)
2018 – November
National Conference on Alternatives to Animal Experiments
Jamia Hamdard, New Delhi, India
2018 – October
2nd Asian Congress on Alternatives*
Guangzhou, China
- Agenda
- BioMed21 presentation (Catherine Willett)
- AOP continuing education course
- Press release
* Humane Society International, co-founder of the BioMed21 Collaboration, is a founding co-organizer and sponsor of the Asian Congress on Alternatives and of the annual Chinese Conferences on Toxicological Alternatives and Translational Toxicology.
2018 – June
China’s 8th Workshop on Alternative Methods*
Shanghai, China
- Agenda
- Presentations
* Humane Society International, co-founder of the BioMed21 Collaboration, co-sponsored China’s 8th Workshop on Alternative Methods
2017 – June
BioMed21: A Human Pathways Approach to Disease Research
National Institutes of Health, Bethesda, Maryland, United States
- Agenda
- Presentations
- Flash report
- Organizing Committee: Chris Austin (NCATS/NIH), Brian Berridge (GSK), Warren Casey (NIEHS/NIH), Suzy Fitzpatrick (FDA), Robert Kavlock (EPA), Troy Seidle (HSI), Anton Simeonov (NCATS/NIH), Dan Tagle (NCATS/NIH), Catherine Willett (HSUS/HSI)
- Final report
2017 – May
BioMed21: Emerging Technology Toward Pathway Based Human Brain Research
D’Or Institute, Rio de Janeiro, Brazil
2015 – December
BioMed21: A Human Pathways Approach to Disease Research
Brussels, Belgium
